The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells

British Journal of Pharmacology

Volumn 134, Issue 4, 2001, Pages 827-836

  Smailbegovic, A ^a   Lever, R ^a   Page, C P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adhesion; Adhesion molecules; Anticoagulant; Endothelium; Heparin; Mononuclear cells; O desulphated heparin; Polyanionic charge; Sulphation

Indexed keywords

CELL ADHESION MOLECULE; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; POLYGLUTAMIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

EID: 0034749819     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704321     Document Type: Article

References (45)

1. Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: Comparison with a low molecular weight heparin
2. Inhibition of allergic late airways responses by inhaled heparin-derived oligosaccharides
3. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin
4. Endothelial binding sites for heparin. Specificity and role in heparin neutralization
5. Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions
6. Effects of dextran sulfate and heparin on lymphocyte localization: Lack of involvement of complement and other plasma proteolytic systems
7. Molecular weight dependent effects of non-anticoagulant heparins on allaergic airways responses
8. Anticoagulant action of heparin
9. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18)
10. In vitro studies of the interaction between heparin and eosinophil cationic protein
11. Selective O-desulphation produces nonanticoagulant heparin that retains pharmacologic activity in the lung
12. Monocyte adhesion to activated aortic endothelium: Role of L-selectin and heparan sulfate proteoglycans
13. New strategies of heparin treatment used to prolong allograft survival
14. Characterisation of the cell surface heterodimer VLA-4 and related peptides
15. The observation of heparin on endothelium after injection
16. Heparins - Anionic polyelectrolyte drugs
17. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins
18. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro
19. Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules
20. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparin
21. Inhibition of T-lymphocyte heparanase by heparin prevents T cell migration and T cell mediated immunity
22. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis
23. Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines
24. The interaction between heparin and polylysine: A circular dichroism and molecular modelling study
25. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
26. Direct expression cloning of vascular cell adhesion molecule 1 (VCAM-1), a cytokine-induced endothelial protein that binds to lymphocytes
27. Inhibition of leucocyte elastase by heparin and its derivatives
28. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity
29. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism
30. Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits
31. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic nontoxic heparin-mimicking compound
32. The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration
33. Heparin inhibits allergen-induced eosinophil infiltration into guinea-pig lung via a mechanism unrelated to its anticoagulant activity
34. Effects of heparin and its desulfated derivatives on leukocyte-endothelial adhesion
35. GMP-140 binding to neutrophils is inhibited by sulfated glycans
36. Inhibition of the enzymatic activity of the first component of complement (Cl) by heparin
37. Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity
38. Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin
39. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation
40. Expression of heparinase by platelets and circulating cells of the immune system: Possible involvment in diapedesis and extravasation
41. 1 (very late antigen-4) dependent
42. Heparin and heparan sulphate are inhibitors of human leucocyte elastase
43. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes
44. Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides
45. Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo